LEADER 02061nam 22007695u 450 001 9910148818403321 005 20211006144809.0 010 $a9783318043945 010 $a331804394X 035 $a(CKB)3780000000102428 035 $a(OCoLC)1046108970 035 $a(SZ-BaSKA)218329 035 $a(MiAaPQ)EBC31865202 035 $a(Au-PeEL)EBL31865202 035 $a(EXLCZ)993780000000102428 100 $a20211006d1973 uy 0 101 0 $aeng 135 $aurunu||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBrain-Pituitary-Adrenal Interrelationships : $eInternational Symposium, Cincinnati, Ohio, June 1972 / $f editors, A. Brodish, E.S. Redgate 205 $a1st ed. 210 $aBasel : $cS. Karger, $d1973 215 $a1 online resource (XII + 340 pages) : $c 182 figures, 29 tables 311 08$a9783805514576 311 08$a3805514573 606 $aAnatomy 606 $aBiochemistry 606 $aCell Biology 606 $aCytology 606 $aEmbryology 606 $aHistology 606 $aMolecular Biology 606 $aPhysiology 606 $aMetabolism 606 $aNeurobiology 606 $aNeurology 606 $aNeurosurgery 606 $aNutrition 606 $aSociology 606 $aVeterinary Medicine 615 14$aAnatomy 615 14$aBiochemistry 615 14$aCell Biology 615 14$aCytology 615 14$aEmbryology 615 14$aHistology 615 14$aMolecular Biology 615 14$aPhysiology 615 24$aMetabolism 615 24$aNeurobiology 615 24$aNeurology 615 24$aNeurosurgery 615 24$aNutrition 615 24$aSociology 615 24$aVeterinary Medicine 676 $a612/.405 700 $aBrodish$b A$01216259 702 $aBrodish$b A. 702 $aRedgate$b E. S. 801 0$bUKSKG 801 1$bUKSKG 906 $aBOOK 912 $a9910148818403321 996 $aBrain-Pituitary-Adrenal Interrelationships$92810850 997 $aUNINA LEADER 03985nam 2200745Ia 450 001 9910140803603321 005 20200520144314.0 010 $a9786612772979 010 $a9781118060322 010 $a1118060326 010 $a9781282772977 010 $a128277297X 010 $a9780470640487 010 $a0470640480 010 $a9780470640470 010 $a0470640472 035 $a(CKB)2670000000043807 035 $a(EBL)588947 035 $a(OCoLC)670278208 035 $a(SSID)ssj0000440475 035 $a(PQKBManifestationID)11308039 035 $a(PQKBTitleCode)TC0000440475 035 $a(PQKBWorkID)10470678 035 $a(PQKB)10271804 035 $a(MiAaPQ)EBC588947 035 $a(Au-PeEL)EBL588947 035 $a(CaPaEBR)ebr10412454 035 $a(CaONFJC)MIL277297 035 $a(PPN)243302770 035 $a(OCoLC)607465382 035 $a(FINmELB)ELB179369 035 $a(Perlego)1009742 035 $a(EXLCZ)992670000000043807 100 $a20100405d2010 uy 0 101 0 $aeng 135 $aur|n||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aOral controlled release formulation design and drug delivery $etheory to practice /$fedited by Hong Wen, Kinam Park 205 $a1st ed. 210 $aHoboken, NJ $cWiley$dc2010 215 $a1 online resource (x, 363 pages) $cillustrations 300 $aDescription based upon print version of record. 311 0 $a9780470253175 311 0 $a0470253177 320 $aIncludes bibliographical references and index. 327 $aORAL CONTROLLED RELEASE FORMULATION DESIGN AND DRUG DELIVERY: Theory to Practice; CONTENTS; PREFACE; CONTRIBUTORS; 1 INTRODUCTION AND OVERVIEW OF ORAL CONTROLLED RELEASE FORMULATION DESIGN; 2 EVOLUTION OF ORAL CONTROLLED RELEASE DOSAGE FORMS; 3 BIOPHARMACEUTIC CONSIDERATION AND ASSESSMENT FOR ORAL CONTROLLED RELEASE FORMULATIONS; 4 PREFORMULATION CONSIDERATION FOR DRUGS IN ORAL CR FORMULATION; 5 POLYMERS IN ORAL MODIFIED RELEASE SYSTEMS; 6 ORAL EXTENDED RELEASE HYDROPHILIC MATRICES: FORMULATION AND DESIGN; 7 COATING SYSTEMS FOR ORAL CONTROLLED RELEASE FORMULATIONS 327 $a8 FLUID BED COATING AND GRANULATION FOR CR DELIVERY; 9 CONTROLLED RELEASE USING BILAYER OSMOTIC TABLET TECHNOLOGY: REDUCING THEORY TO PRACTICE; 10 FAST DISINTEGRATING TABLETS; 11 BUCCAL DRUG DELIVERY SYSTEMS; 12 ORAL TARGETED DRUG DELIVERY SYSTEMS: GASTRIC RETENTION DEVICES; 13 ORAL TARGETED DRUG DELIVERY SYSTEMS: ENTERIC COATING; 14 ORALLY ADMINISTERED DRUG DELIVERY SYSTEMS TO THE COLON; 15 DISSOLUTION TESTING: IN VITRO CHARACTERIZATION OF ORAL CONTROLLED RELEASE DOSAGE FORMS; 16 CHALLENGES AND NEW TECHNOLOGIES OF ORAL CONTROLLED RELEASE 327 $a17 ORAL CONTROLLED DRUG DELIVERY: QUALITY BY DESIGN (QbD) Approach to Drug Development; 18 ORAL CONTROLLED RELEASE-BASED PRODUCTS FOR LIFE CYCLE MANAGEMENT; 19 GENERIC ORAL CONTROLLED RELEASE PRODUCT DEVELOPMENT: FORMULATION AND PROCESS CONSIDERATIONS; 20 THE SCIENCE AND REGULATORY PERSPECTIVES OF EMERGING CONTROLLED RELEASE DOSAGE FORMS; INDEX 330 $aThis book describes the theories, applications, and challenges for different oral controlled release formulations. This book differs from most in its focus on oral controlled release formulation design and process development. It also covers the related areas like preformulation, biopharmaceutics, in vitro-in vivo correlations (IVIVC), quality by design (QbD), and regulatory issues. 606 $aDrugs$xControlled release 606 $aOral medication 615 0$aDrugs$xControlled release. 615 0$aOral medication. 676 $a615/.6 701 $aWen$b Hong$f1967-$0889127 701 $aPark$b Kinam$0149615 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910140803603321 996 $aOral controlled release formulation design and drug delivery$91986588 997 $aUNINA